Kewaunee Scientific Corporation (KEQU) 股票分析

公司概述

Kewaunee Scientific Corporation specializes in the design, manufacture, and installation of laboratory, healthcare, and technical furniture alongside essential infrastructure products, serving a niche industrial market. The company operates within the Consumer Cyclical sector, specifically classified under the industry of Furnishings, Fixtures & Appliances, which implies its business performance is closely tied to broader economic cycles and discretionary spending on specialized equipment. Its operational scale is characterized by a market capitalization of $97.74M, an annual revenue of $287.75M, and a workforce comprising 1239 employees across its Domestic and International segments. These valuation and revenue figures indicate that the company functions as a small-cap entity with a significant revenue base relative to its size, suggesting a mature business model that generates substantial top-line sales despite its modest market valuation. The presence of over 1,200 employees further underscores the company's established footprint in producing steel and wood casework, fume hoods, and adaptable modular systems for specialized sectors.

财务健康

The company reported a trailing twelve-month revenue of $287.75M and net income of $11.08M, while generating EBITDA of $26.02M, revealing a cost structure where operating expenses consume a significant portion of top-line earnings to arrive at the final profit. The gap between the $287.75M revenue and the $11.08M net income highlights a net profit margin of 3.9%, indicating that for every dollar of sales, less than four cents remains as net profit after all obligations are met. Free cash flow stood at $15.47M, demonstrating that the business generates positive cash after capital expenditures, which provides a degree of financial flexibility to cover operational needs or return capital, albeit on a modest scale relative to total revenue. The gross margin is recorded at 28.9%, the operating margin at 3.7%, and the profit margin at 3.9%; these figures collectively suggest a low-margin business model typical of manufactured industrial goods where pricing power may be limited by competition. On the balance sheet, cash holdings of $8.15M are significantly lower than total debt of $59.34M, resulting in a debt-to-equity ratio of 81.82, which indicates a highly leveraged capital structure that relies heavily on debt financing rather than equity. The current ratio is 2.12, signaling that the company possesses more than double the current assets required to meet its short-term liabilities, pointing to robust short-term liquidity despite the high debt load. Return on Equity is 17.4% while Return on Assets is 6.8%, revealing that the company is effective at generating returns on shareholder capital but that asset utilization efficiency is moderated by its heavy debt obligations and asset base size.

估值评估

The trailing P/E ratio is 9.17 while the forward P/E is 15.79, and the difference between these metrics implies that the market expects earnings growth to slow down or that current earnings are temporarily depressed relative to future expectations. The price-to-book ratio stands at 1.38, indicating that the stock trades at a slight premium of 38% over its book value, which suggests investors value the company's intangible assets or future growth potential slightly above the tangible asset base. Alternative valuation metrics include a price-to-sales ratio of 0.34 and an EV/EBITDA of 5.79, suggesting the stock is priced very cheaply relative to its sales and earnings before interest, taxes, depreciation, and amortization, which often points to a cyclical bottom or specific sector headwinds. The 52-week high is $60.89 and the 52-week low is $30.33, meaning the current price sits significantly below the recent peak, reflecting a correction from recent highs or a prolonged period of underperformance relative to the recent trading range. The beta value is 0.67, indicating that the stock exhibits lower price volatility relative to the broader market, moving less aggressively than the overall index during periods of market fluctuation.

Growth & Income

Revenue growth year-over-year is 3.3% while earnings growth year-over-year is -48.9%, illustrating that earnings are growing significantly slower than revenue or are actually contracting while sales expand, which implies rising costs or one-time charges impacting the bottom line more severely than the top line. Since the company does not pay a dividend, the dividend yield is N/A and the payout ratio is 0.0%, indicating that the firm retains all its earnings rather than distributing them to shareholders. This reinvestment strategy suggests the management prioritizes internal funding for operations, debt reduction, or capacity expansion over providing current income to investors. The overall growth and income profile is characterized by steady but modest top-line expansion accompanied by a sharp decline in profitability, with no income distribution mechanism currently in place for shareholders.